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In the embryonic chicken skin, feather buds and the intervening interbud tissue form in a reiterated and sequential pattern that is
dependent on interactions between the epidermis and dermis. Feather promoting and inhibiting signals such as fibroblast growth factors
(FGF) and bone morphogenetic proteins (BMP), respectively, direct the formation of this periodic pattern. However, the transcription factors
that mediate the response to these signals and transmit this information to downstream effector genes are largely unknown. Here we have
explored the DLX transcription factors as candidate transcriptional mediators downstream of the described feather patterning signals. We
show that several Dlx members are expressed in the dermis and epidermis of the developing feather buds and their expression is induced in
embryonic chick skin by the ectopic activation of BMP and FGF signaling. Misexpression of Dlx in the chick skin leads to both feather loss
and feather bud fusions, suggesting that DLX proteins play a negative as well as a positive role in feather development. Moreover, DLX
regulates the expression of NCAM and tenascin, molecules that are important for feather bud initiation as well as bud outgrowth and
morphogenesis. Our results suggest that DLX transcription factors serve to integrate and transduce feather patterning signals to downstream
effector molecules.
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IntroductionThe development of the chick feather field is a recog-
nized model for the study of the generation of a periodic and
reiterating pattern as well as the formation of individual skin
appendages. Feathers develop in independent tracts (spinal,
humeral, femoral, and others) and within each tract they
arise progressively, forming a hexagonal array (Sengel,
1976). First, a single row of feather buds is initiated within
a tract, then, additional rows are formed lateral to the
original row. Before feather bud formation (Hamburger–
Hamilton (HH) stage 28 of development), the mesenchyme
of the presumptive tract condenses to form a dense dermis
(Hamburger and Hamilton, 1951; Mayerson and Fallon,
1985; Wessels, 1965). Later (HH stage 30), the dermis0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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formation of epidermal placodes of columnar epithelium.
The epidermal placode in turn signals to the dermis and
induces formation of dermal condensations through migra-
tion and compaction of the dermal cells beneath the placode
to form a short bud. The dermal condensation then influen-
ces the epidermis to promote feather bud outgrowth. Re-
combination studies in embryonic chick skin have shown
that reciprocal epidermal–dermal interactions are essential
for feather initiation and development and that in the early
stages (until the short bud stage), the feather field is flexible
and the placode/interplacode fates are reversible (Chuong et
al., 1996; Linsenmayer, 1972; Sengel, 1963).
Establishment of the periodic pattern of the feather tract
involves competitive signaling of feather promoting and
inhibitory factors. Members of the Fgf family have been
shown to serve as positive feather promoting signals during
the early stages of bud development. Fgf2 and Fgf4 are
expressed in the epidermal placode and later Fgf4 and Fgf10
are found in the dermal condensations (Jung et al., 1998;
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Fibroblast growth factor (FGF) receptors are expressed in a
diffuse manner in the ectoderm and dermis before feather
bud initiation. During the early stages of bud development,
specific FGF receptors are expressed in the placode, dermal
condensations, and interplacodal areas (Noji et al., 1993;
Song et al., 1996). The evidence that FGF signaling acts to
promote feather development comes from studies in which
FGF induces feather formation in the chicken scaleless
mutant that does not form most feathers, and in wild-type
chick skin (Song et al., 1996; Widelitz et al., 1996).
Bone morphogenetic proteins (BMP) have been shown to
play an inhibitory role in early feather bud formation (Jung
et al., 1998; Noramly and Morgan, 1998). It has been
suggested that BMP proteins antagonize primary inductive
signals from the dermis as well as local secondary inductive
signals and in this way mediate lateral inhibition during the
early patterning of the feather tract (Noramly and Morgan,
1998). Before placode formation, Bmp2 is expressed in the
epithelium in a diffuse pattern and later is expressed in both
the epidermal placode and dermal condensations. Bmp4 is
expressed in dermal condensations during early bud devel-
opment (Noramly and Morgan, 1998). BMP receptors IA
and IB are expressed in a diffuse manner in the chick skin
before bud formation and later become down-regulated in
the interbud regions (data not shown).
Several other molecules have also been described as
either feather promoting or inhibitory factors involved in
early feather field patterning (Atit et al., 2003; Crowe et al.,
1998; Morgan et al., 1998; Noramly et al., 1999; Ting-
Berreth and Chuong, 1996a,b). Thus, feather initiation and
later development depends on the balance between induc-
tive and inhibitory signals expressed in the feather field.
How this balance is achieved and what are the downstream
transcription factors and target genes that mediate propaga-
tion of the feather field and feather bud/interbud interactions
and development are important questions that are still
unresolved. Here we have explored the DLX transcription
factors as candidate molecules downstream of the described
feather patterning signals.
Dlx genes are vertebrate homologs of the Drosophila
homeobox containing Distal-less gene. There are six known
Dlx genes in mice and humans (McGuinness et al., 1996;
Nakamura et al., 1996; Porteus et al., 1991; Price et al.,
1991; Robinson and Mahon, 1994; Robinson et al., 1991;
Scherer et al., 1995; Simeone et al., 1994; Stock et al.,
1996; Weiss et al., 1994), eight in Zebrafish (Akimenko et
al., 1994; Ekker et al., 1992; Ellies et al., 1997; Stock et al.,
1996), and four Dlx genes have been described in the chick
(Dhawan et al., 1997; Fernandez et al., 1998; Ferrari et al.,
1995; Pera and Kessel, 1999; Puelles et al., 2000). In mice
and humans, Dlx genes are organized in three convergently
transcribed pairs (linked to Hox clusters): Dlx1 and Dlx2,
Dlx3 and Dlx4, Dlx5 and Dlx6 (McGuinness et al., 1996;
Nakamura et al., 1996; Ozcelik et al., 1992; Simeone et al.,
1994; Stock et al., 1996). On the basis of sequencesimilarities including the homeodomain, the Dlx genes
can be divided into two large groups (clades): Dlx2,
Dlx3, and Dlx5; and Dlx1, Dlx4, and Dlx6 (Ellies et al.,
1997; Stock et al., 1996). During development, Dlx genes
are expressed in various tissues and organs, such as brain,
cranial neural crest derivatives, surface ectoderm, differen-
tiating skeletal tissues, developing teeth, and hematopoietic
cells (Acampora et al., 1999; Akimenko et al., 1994;
Bulfone et al., 1993; Chen et al., 1996; Davideau et al.,
1999; Depew et al., 1999; Dolle et al., 1992; Eisenstat et
al., 1999; Fernandez et al., 1998; Ferrari et al., 1995;
Myojin et al., 2001; Pera and Kessel, 1999; Price et al.,
1991; Qiu et al., 1997; Robinson and Mahon, 1994;
Robinson et al., 1991; Shimamoto et al., 1997, 2000;
Simeone et al., 1994; Thomas et al., 1997; Xu et al.,
2001). Usually the members of the same linkage group
and/or the same clade are expressed in partially overlapping
domains (Zerucha and Ekker, 2000). This, as well as
sequence similarities, suggests that Dlx genes have partially
redundant functions. Indeed, analysis of mice mutant for
Dlx1, Dlx2, or Dlx5 or doubly mutant for Dlx1/Dlx2, Dlx5/
Dlx6, or Dlx2/Dlx5 has shown that these genes are partially
redundant for the development of different tissues and
organs, such as limbs, craniofacial and axial skeleton, and
nervous system (Acampora et al., 1999; Anderson et al.,
1997a,b; Panganiban and Rubenstein, 2002; Qiu et al.,
1997; Robledo et al., 2002). Some functional similarities
of Dlx genes have also been observed in misexpression
studies, when Dlx2 and Dlx5, which belong to the same
clade (but not Dlx1—a member of the other clade) had a
similar effect on the differentiation of GABAergic neurons
in the mouse brain (Stuhmer et al., 2002).
The Dlx genes mediate epithelial–mesenchymal interac-
tions and act downstream of FGF8 and BMP4 during tooth
development (Acampora et al., 1999; Bei and Maas, 1998;
Qiu et al., 1997; Robledo et al., 2002; Thomas et al., 1997,
2000). Before initiation of tooth development, Dlx1, Dlx2,
Dlx5, and Dlx6 genes are expressed in the epithelium and
mesenchyme of the mandibular molar region of the first
branchial arch, although only Dlx1 and Dlx2 are expressed
in the maxillary molar region (Qiu et al., 1997). In Dlx1/
Dlx2 mutants, maxillary molars do not develop beyond the
lamina stage due to inability of the mutant mesenchyme to
respond to the initial odontogenic signals from the epithe-
lium (Thomas et al., 1997). In the presumptive molar
mesenchyme (proximal regions of the first branchial arch),
Dlx1 and Dlx2 expression is regulated by FGF8 (Bei and
Maas, 1998; Thomas et al., 2000). In the distal regions of
the first arch, Dlx2 expression is under the control of BMP4
(Thomas et al., 2000).
Another example of an epithelial appendage whose
development is controlled by a series of epithelial–mes-
enchymal interactions is hair. The role of Dlx genes in hair
development has not been investigated, although a muta-
tion in the human Dlx3 gene was found to be responsible
for tricho-dento-osseous (TDO) syndrome characterized by
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1998a,b). In mouse skin, Dlx3 is expressed in the matrix
cells of the hair follicles and the suprabasal cells of
interfollicular epidermis (Morasso et al., 1994; Robinson
and Mahon, 1994). Dlx3 mutant mice die at midgestation
and are not informative for the analysis of skin develop-
ment, whereas misexpression of Dlx3 in epidermal basal
cells in transgenic mice suggests that this gene has a role
in regulating epidermal differentiation (Morasso et al.,
1996, 1999).
Here we have examined the possible role of Dlx genes in
feather bud formation. We show that several Dlx members
are expressed in the epithelium of the presumptive feather
field before bud initiation and then in a dynamic manner in
the dermis and epidermis of the developing buds. Dlx genes
are induced in chick skin by the ectopic activation of BMP
and FGF signaling and thus may mediate the inhibitory
effects of BMP and the positive effects of FGF during early
patterning of feather primordia. Misexpression of Dlx in the
chick skin results in a complex phenotype, leading to both
feather loss and feather bud fusions. These data suggest that
DLX may play a negative as well as a positive role in feather
development and in this way may integrate both feather
promoting and inhibitory signals. DLX induces expression
of NCAM and tenascin, molecules that are important for
feather bud initiation as well as later bud outgrowth and
morphogenesis (Jiang and Chuong, 1992).Materials and methods
RNA in situ hybridization
White Leghorn chicken eggs were obtained from SPA-
FAS and incubated at 39jC. Embryos or skin explants were
fixed and processed as described for either whole mount
RNA in situ hybridization (Henrique et al., 1995) or for
paraffin sectioning and RNA in situ hybridization (Neubuser
et al., 1995). Modifications to the whole mount procedure
included proteinase K concentration of 5 or 7 Ag/ml and use
of BM purple substrate (Roche) in place of BCIP/NBT.
The cDNA probes used for in situ hybridization were as
follows: the c-Dlx2 cDNA was provided by John L.R.
Rubenstein; the c-Dlx3 cDNA was obtained from Michael
Kessel; c-Dlx5 cDNA was constructed by subcloning a
cDlx5 coding sequence into Bluescript SK+, c-Bmp2 was
provided by Paul M. Brickell, c-Lef cDNA was constructed
by subcloning a cDNA fragment from RCASBP(A)/c-Lef
(obtained from Juan Carlos Izpisua Belmonte) into Blue-
script SK+.
Explant culture
Explant cultures were performed according to Jung et al.
(1998). Heparin acrylic beads (Sigma, H5263) were prepared
and soaked in PBS or FGF-4 (1 mg/ml; Genetics Institute) aspreviously described (Niswander et al., 1993). At the start of
culture, beads were placed in the lateral areas of the skin
explant. The explants were incubated for 2 days at 37jC,
then fixed and processed for RNA in situ hybridization.
Viral infection
RCASBP(A)/Dlx2 and RCASBP(B)/Dlx5 were con-
structed by subcloning full-length cDNA sequences of
mouse Dlx2 and Dlx5 into the ClaI site of RCAS plasmid.
Transfection and growth of RCAS viruses were performed
as described by Morgan and Fekete (1996). Concentrated
virus was injected either on top of the ectoderm of
Hamburger and Hamilton (1951) stage 11–13 embryos
to achieve widespread infection or into the amniotic cavity
of stage 20 embryos for infection predominantly localized
to the skin.
Detection of proliferating cells
Proliferation was assessed by incorporation of BrDU
(Sigma). BrDU labeling was accomplished by injecting 2
mg of BrDU into the cavity of stage 35 embryos. The
embryos were fixed after 2 h of incubation at 39jC, skin
was removed and processed for immunohistochemistry as
described elsewhere (Atit et al., 2003).
Immunohistochemistry
Dorsal skin of the manipulated and control embryos was
removed, fixed, and prepared for immunohistochemistry as
described previously (Atit et al., 2003). NCAM and tenascin
were detected by using a 1:100 dilution of 5e and a 1:50
dilution of M1-B4 monoclonal antibody respectively (De-
velopmental Studies Hybridoma Bank) in blocking buffer
(PBS plus 2% heat-treated goat serum and 1% BSA). DLX
proteins were detected by 1:50 dilution of rabbit polyclonal
Distal-less antibody (a kind gift of Grace Panganiban and
Jhumku Kohtz (Panganiban et al., 1995)) in blocking buffer
(PBS, 2% heat-treated goat serum, 0.1% Triton X-100).
Viral gag protein was detected by AMV3C2 antibodies
obtained from Developmental Studies Hybridoma Bank.
Msx proteins were detected by 4G1 monoclonal antibody
(DSHB). Species-appropriate secondary antibodies conju-
gated to Cy3 (Jackson Immuno Research Labs) were used at
a 1:200 dilution in blocking buffer.Results
Expression of Dlx genes and proteins during feather bud
development
Dlx2 and Dlx3 have similar patterns of expression in the
developing feather bud. At stages 29–30, Dlx2 and Dlx3
transcripts are detected in the epidermal placodes and in a
Fig. 1. Expression of Dlx2, Dlx3, and Dlx5 genes during early feather bud development. Expression of Dlx genes was detected by RNA in situ hybridization
(A–I, top panels are whole mount in situs, rostral at top; bottom panels are [A–F] cryosections of whole mount processed embryos or [G–I] paraffin section in
situ hybridization, rostral to the left). (A, D, G) At stage 30, Dlx2 and Dlx3 are expressed in the epidermal placode (A, D, arrows) and throughout the lateral
epidermis (asterisks). Dlx5 is expressed in the dermal condensation (G, arrows). (B, E, H) At stage 33, Dlx2 and Dlx3 are expressed in the bud epidermis (B, E)
and Dlx5 is expressed in both the epidermis and dermis (H). During the symmetric short bud stage, Dlx5 is expressed throughout the bud epidermis and dermis
(H, middle). During the asymmetric short bud stage, Dlx5 is enriched in the anterior bud epidermis and dermis (H, bottom). (C, F, I) At stage 35, Dlx2, Dlx3,
and Dlx5 are expressed in the bud epidermis. The top panels of A, D, G are shown at 2 higher magnification than other whole-mount images; the middle and
bottom panels are shown at the same magnification; hatched black lines demarcate the epidermis (e) and dermis (d).
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Fig. 2. Activated BMP receptor and FGF induce Dlx gene expression in chicken skin. Dlx5 (A), Dlx2 (B), and Dlx3 (C) expression detected at stage 34 by
whole mount in situ hybridization after misexpression of constitutive active BMP Receptor-IB (caBMPR-IB; top panels) or Noggin (middle panels). Control
skin shown in bottom panels. Embryos injected with caBMPR-IB/RCAS at stage 20 display uniform induction of Dlx gene expression in the areas of bud loss
(A and B, top panels; white arrowheads), smaller patches of ectopic Dlx gene expression are found in relatively unperturbed bud rows (A and C; black arrows).
Cross sections through caBMPR-IB-infected skin indicate that DLX proteins are induced in the epidermis and underlying dermis (E, F). In unaffected skin,
DLX proteins are expressed at normal levels in the feather buds and are not expressed in the interbud regions (D). DLX protein and RCAS virus expression
detected with Distal-less-specific and with gag-specific antibodies, respectively. Noggin/RCAS injection at stage 20 causes feather bud fusion. In the fused
buds, Dlx genes are expressed at normal (B and C, middle panels; white arrowheads) or lower levels (A and B; black arrows). (G–J) FGF4 induces Dlx gene
expression in the chick skin. Skin explants prepared from stage 30 chick embryos were treated with (H–J) FGF4 (1 mg/ml)-coated beads or (G) control beads
soaked in PBS. The beads are indicated with asterisks. After 2 days in culture, the explants were processed for in situ hybridization with Dlx2, Dlx3, and Dlx5
RNA probes. The feathers in the control explants develop normally (G). In the explants treated with FGF4-coated beads, Dlx genes are induced (arrows) in the
ectopic bud-like structures next to the beads (H–J).
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where the next rows of buds will form (Figs. 1A and D).
Later when additional rows form, Dlx2 and Dlx3 are
detected in the bud and only weakly in the lateral epithelium
(Figs. 1B, C, E, F, and not shown). During all the stages
examined (stages 29–35), no expression of Dlx2 and Dlx3
is observed in the bud mesenchyme.
Dlx5 transcripts first appear in dermal condensations of
the forming feather buds (Fig. 1G). Later, Dlx5 is also
expressed in the bud epidermis (Fig. 1H, middle, represents
more lateral and hence less mature buds of a stage 33
embryo; this is similar to expression in bud epidermis at
developmentally younger stages 31 and 32 of chick devel-
opment, data not shown). As the bud matures (stage 33–
34), Dlx5 becomes asymmetrically enriched in the anterior
bud epithelium and dermis (Fig. 1H, top and bottom). In the
outgrowing bud (stage 35), Dlx5 is expressed throughout the
bud epithelium and disappears from the dermis (Fig. 1I).
Thus, in the early stages of bud development (stages 29–
30), Dlx5 is expressed in a complementary pattern to Dlx2
and Dlx3: Dlx5 in the dermis and Dlx2 and Dlx3 in the
epithelial placode. Later in development, the expression of
Dlx5 partially overlaps with the expression of Dlx2 and
Dlx3. At later stages Dlx5, Dlx2, and Dlx3 are all expressed
in the bud epithelium.
To examine DLX protein expression, we used anti-
Distal-less antibodies which cross-react with DLX1,
DLX2, and DLX5 in mouse (Panganiban et al., 1995;
Stuhmer et al., 2002). In the early stages of bud develop-
ment (stages 30–32), DLX proteins are found in the dermal
condensations and the placode (Fig. 4A). At stage 33, DLX
proteins are evenly distributed throughout the bud dermis
and epidermis (Fig. 4E). At stage 34, DLX proteins are
expressed in the anterior bud dermis and throughout the bud
epithelium with a stronger expression in the anterior epithe-
lium (Fig. 4I). At stage 35, DLX proteins are detected in the
epithelium of the bud and very weakly in the dermis (Fig.
4M). Although it is possible that other Dlx genes are also
expressed in the forming feather field, the DLX protein
expression in the buds is consistent with the RNA expres-
sion of Dlx2, Dlx3, and Dlx5. The expression pattern of Dlx
genes and proteins suggests a role in epidermal–dermal
interactions during early stages of bud development and at
later stages in feather growth and differentiation.
Activated BMP receptor I and FGF induce Dlx genes in
chicken skin
The expression of Dlx genes during feather development
resembles that of Bmp genes (Noramly and Morgan, 1998).
Previous studies provided evidence that BMP proteins play
multiple roles in feather tract formation. BMPs specify sites
of bud initiation, mediate lateral inhibition to establish
spacing between forming feather buds, and regulate pat-
terning of the bud itself (Noramly and Morgan, 1998; Scaal
et al., 2002). Misexpression of BMP2 and BMP4 in chickenskin causes inhibition of feather formation (Jung et al.,
1998; Noramly and Morgan, 1998), as does an activated
BMP receptor (Ashique et al., 2002). To ectopically acti-
vate BMP signaling in the embryonic chicken skin, we used
a replication competent retroviral vector (RCAS) expressing
constitutive-active BMPR-IB (ca BMPR-IB) (Zou et al.,
1997). Virus was injected into the amniotic cavity of stage
20 chick embryos. After 5 days of incubation, embryos
were harvested and analyzed for expression of Dlx genes by
in situ hybridization. Misexpression of caBMPR-IB
resulted in widespread feather bud loss as expected (n =
16). We also observed induction of Dlx2 (n = 5), Dlx3 (n =
5), and Dlx5 (n = 6) genes in the areas of bud loss (Figs.
2A–C, top panels; white arrowheads). In areas of relatively
unperturbed rows, Dlx genes were induced as ectopic
patches in the interbud regions (Figs. 2A and C, top; black
arrows). Analysis of cross sections of the affected skin
revealed that viral infection had spread through the epithe-
lium and the underlying mesenchyme (Fig. 2F). DLX
expression was induced at high levels in the epithelium
and at lower levels in the underlying mesenchyme (Fig.
2E). The induction of Dlx expression by BMP may suggest
that the inhibition of feather bud initiation by BMP signal-
ing is partially mediated by DLX activation. Though Dlx
molecules are not normally expressed in the interbud skin,
Dlx2 and Dlx3 are expressed in a diffuse pattern in the
ectoderm lateral to the primary row at the beginning of the
establishment of the hexagonal array and may play an
inhibitory role at this stage.
To test if inhibition of BMP signaling affects Dlx
expression, we performed injections with RCAS virus
expressing a BMP inhibitor Noggin. As previously de-
scribed (Noramly and Morgan, 1998), Noggin misexpres-
sion produced phenotypes complementary to BMP
misexpression: feather bud fusions and irregularly shaped
feathers (n = 8). In several areas of feather bud fusions, Dlx
genes were expressed at lower levels than usual (Figs. 2B
and C, middle panels; white arrowheads). In other areas of
fusions, Dlx genes were expressed at apparently normal
levels (Figs. 2A and B, middle panels; black arrows). This
may be due to the existence of other signals acting
upstream of Dlx and parallel to BMPs. One such known
signaling molecule is FGF8, which induces Dlx1 and Dlx2
in developing tooth (Bei and Maas, 1998; Thomas et al.,
2000). FGFs act to promote feather bud formation (Song et
al., 1996; Widelitz et al., 1996) and thus may serve to
regulate Dlx expression. To explore this possibility, we
made use of a skin explant culture system (Jung et al.,
1998). Dorsal skin derived from stage 30 chick embryos
was cultured in the presence of a localized source of 1 mg/
ml FGF4 protein using a heparin-coated bead applied to the
lateral regions of the explant where feather buds were not
yet formed. After 2 days of culture, ectopic buds and bud
fusions occurred around the FGF4-coated beads and Dlx2
(n = 6 beads), Dlx3 (n = 6 beads), and Dlx5 (n = 5 beads)
were induced in these bud-like structures (Figs. 2H–J). In
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normal development of the feather array and expression of
Dlx genes (Fig. 2G). These results indicate that Dlx gene
expression is positively regulated by feather promoting and
inhibitory signals.
Dlx misexpression results in feather bud fusion and loss of
feathers
To study if Dlx genes play a role in feather formation,
we misexpressed Dlx2 and Dlx5 in chick embryos. RCAS/
Dlx2 and RCAS/Dlx5 viruses were injected above the
embryonic ectoderm at stages 11–13, resulting in wide-
spread infection (Figs. 3I–R), or into the amniotic cavity
at stages 20–22, resulting in localized patches of infection
of the epidermis and dermis (data not shown). Embryos
were then re-incubated and analyzed at day 7, 8, or 11.5 of
development.
Dlx2 misexpression resulted in two phenotypes in the
areas of infection: fusion of feather buds and loss of buds.
These two phenotypes were observed in the same embryos
(n = 20). Fusion of buds occurred in different patterns: most
commonly observed were bud fusions along the medial–
lateral axis; fusion of buds along the anterior–posterior (A–
P) axis also occurred, in rare instances, several buds from
different rows fused together to form a single structure with
no particular lateral or A–P orientation. Areas of feather
loss were often located next to the areas of feather fusions.
Feather buds that formed near areas of loss or fusion were of
abnormal shape and size and were not properly organized in
a hexagonal array (Figs. 3A–C).
At day 11.5, RCAS/Dlx2-injected embryos exhibited
large areas where development of feathers was inhibited
(n = 4) (Fig. 3E, asterisks). In areas where the feathers
formed, the feathers were often abnormally shaped, shorter,
thicker, and sometimes much wider at the distal tip than at
the base (Figs. 3E and G), resembling deformed feathers in
BMP-injected embryos. Some feathers were unusually wide
which suggests that these had evolved from the fused buds
(Fig. 3H, arrow). Some feathers were round, small, and
stunted in development (Fig. 3E, arrow). The pattern of the
hexagonal array, especially in the areas close to the regions
of feather loss, was perturbed (Fig. 3E). These phenotypes
imply that Dlx2 may have both an inhibitory and an
inductive role in feather bud initiation as well as a role in
later patterning of individual buds.
Since development of the feather tract has a mediolateral
progression, misexpression of Dlx2 will affect lateral buds at
earlier stages of development than medial buds. In Figs. 3I–
R, we followed the time course of infection and correlated
the phenotypes with the extent of infection. In our experi-
ments, strong RCAS/Dlx2 misexpression in the lateral
region completely inhibited bud initiation (Figs. 3K, M, P,
R). Histological analysis showed that neither epidermal
placodes nor dermal condensations formed in these areas,
and the morphology of the skin was normal with uniformlydense dermis and epidermis. RCAS/Dlx2 infection of buds
whose development had already initiated led to the forma-
tion of fused buds (Figs. 3L, N, O, Q). In older buds, Dlx2
misexpression did not suppress bud development or cause
bud fusion, but affected the morphology of the bud itself.
Dlx5 misexpression at stages 11–13 resulted in feather
fusions and loss (n = 8) and changes in feather morphology
similar to Dlx2 injections (data not shown); however, the
phenotypes produced by Dlx2 were stronger and more
consistent. The reason for this is unclear and may be related
to our observation that Dlx5 misexpression is not well
tolerated during viral production. The remaining studies
were conducted on embryonic skin infected with Dlx2.
RCAS injections of another homeobox gene Msx1 that is
also expressed during feather development (Noveen et al.,
1995), caused feather bud loss (n = 15), but never fusion of
feathers (IR and LN, unpublished data). Therefore, we
conclude that the phenotypes generated by Dlx2 and Dlx5
are specific for Dlx family members.
Dlx misexpression alters cell proliferation in feather buds
To begin to understand the mechanism by which ectopic
expression of Dlx affects feather morphogenesis, we exam-
ined proliferation by BrdU incorporation (n = 5). Specific
distribution of proliferating cells in the developing bud is
important for bud outgrowth and specification of bud
morphology. Before epithelial placode formation, prolifer-
ating cells are evenly distributed throughout the epidermis
and dermis (Desbiens et al., 1991). Proliferation is greatly
reduced in the epidermal placodes and dermal condensa-
tions as they form, whereas the interbud epidermis exhibits
elevated DNA synthesis (Fig. 4B). As the feather buds grow
out, proliferation in the interbud is reduced, but it is
significantly increased in the bud dermis (Fig. 4F). At the
asymmetric bud stage, proliferation is largely restricted to
the posterior dermis and bud epithelium (Fig. 4J). During
bud elongation, proliferation in the dermis is localized to the
posterior bud (Fig. 4N).
Ectopic DLX2 expression was detected with anti-Myc
antibodies. In the less affected areas of the skin with normal
looking buds, only a few cells expressed Myc-DLX2, and
BrdU incorporation was similar to control skin. In areas of
bud fusion, Myc-DLX2 was strongly expressed in the
former interbud regions and there were significantly more
BrdU-positive cells than in the control interbuds (Fig. 5C).
In the areas of bud loss, we did not observe any signs of the
formation of dermal condensations or placodes. Myc-DLX2
was expressed at high levels and BrdU-positive cells were
randomly distributed through the epidermis and underlying
dermis at higher levels compared to the levels in normal
featherless skin or interbud regions (Fig. 5D). The prolifer-
ation pattern and cell density in the Dlx2-infected skin with
bud loss resembled the state of dermal densification before
the onset of feather germ formation. This suggests that Dlx2
misexpression in the chick skin at early stages prevents
Fig. 3. Misexpression of Dlx causes feather bud loss, fusion, and a change of feather shape. (A–C) Embryos infected with Dlx2/RCAS at stage 13 (A, B)
and stage 20 (C) were processed for in situ hybridization of Lef1 RNA (A, B) and Bmp2 RNA (C) at stage 35. Feather fusions are indicated with arrows
and the areas of feather loss are marked with asterisks. Fusions most commonly occur along the medial– lateral axis (B, bottom arrow; C). Fusions are also
observed along the anterior–posterior axis (B, top arrow) and along both axes (A, arrow). (D–H) Embryos injected with Dlx2/RCAS at stage 20 were
analyzed at stage 37 (E–H) and compared with control embryos of the same stage (D). Feathers were visualized by in situ hybridization of Dlx5 RNA.
Feathers in control embryos have a characteristically elongated shape (D; magnified in F, arrows). The Dlx2/RCAS-infected embryos exhibit large areas of
feather loss (E, asterisks) and areas of abnormally shaped (E, arrow; magnified in G, arrow) and fused (magnified in H, arrow) feathers. Black hatched lines
in H demarcate abnormally shaped, but not fused feathers; white hatched line demarcates a fused feather. (I –R) Ectopic DLX expression in the injected
chick skin. After injection with Dlx2/RCAS at stage 13 (day 1.8 of embryonic development), embryos were analyzed for ectopic protein distribution and
phenotypes at day 4, 6, 7, and 8 of development. Ectopic DLX protein was visualized with anti-myc antibodies (I–L, O, P), forming feather buds were
visualized with anti-Msx antibodies (M, N, Q, R). At day 4, ectopic DLX proteins are expressed in the chick skin at very low levels in both the medial and
lateral regions (I, arrows). At day 6, the levels of ectopic DLX are relatively higher (J). At day 7, the buds are already forming (M, N). Ectopic DLX
expression is observed at higher levels in the regions devoid of buds (K, M, lateral) than in the regions where buds are forming (K, M, medial; L, N,
arrow). Bud fusions are already observed in the medial areas of skin (L, M, arrow). By day 8, ectopic DLX is strongly expressed throughout the skin (O,
P). Ectopic DLX levels are higher in the areas of bud loss (P, R) than in the areas where buds are present and fused (O, Q, arrow). Hatched lines demarcate
a skin section (I) and the epidermis (e) and dermis (d) (J–R).
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Fig. 4. Expression of DLX, NCAM, and tenascin proteins and cell proliferation during early feather development. Cross sections of skin from chick embryos at
stages 31–35 were processed with antibodies against Distal-less, BrdU, NCAM, and tenascin. Anterior at the left, posterior at the right; hatched lines demarcate
the epidermis (e) and dermis (d). During formation of dermal condensations (stage 31, A–D), DLX and NCAM proteins appear in the dermal condensations
and epidermal placodes (A and C, arrows), proliferation is greatly decreased in the dermal condensations and placodes (B, arrows), tenascin is expressed in the
epidermal placodes and dermal condensations with strongest expression at the border between the two layers (D, arrows). During the symmetric short bud stage
(stage 33, E–H), DLX proteins are expressed in the bud epidermis and dermis (E, arrow), cell proliferation is increased in the bud dermis (F, arrow; interbud,
arrowhead), NCAM (G) and tenascin (H) are expressed in the bud epidermis and dermis (arrows) with tenascin displaying a strong signal at the border. During
the asymmetric short bud stage (stage 34, I–L), DLX proteins are expressed in the bud epithelium and the anterior bud dermis (I, arrow), proliferation is
increased in the bud and largely restricted to the posterior dermis and bud epithelium (J, bud—arrow, interbud—arrowhead), NCAM and tenascin are enriched
in the anterior bud dermis (K, L, arrows) with NCAM being expressed in the distal and tenascin in the anterior bud epidermis. As the bud continues to elongate
(stage 35, M–P), DLX proteins are detected throughout the bud epithelium (M, arrow) with faint staining in the bud dermis, proliferation is highest in the
posterior bud epidermis and dermis (N, arrow) and reduced in the interbud areas (N, arrowhead), NCAM and tenascin are expressed in the anterior bud dermis
(arrows) and also appear in a separate domain of the posterior dermis (O, P), NCAM and tenascin continue to be expressed in the distal and anterior bud
epithelium, respectively (O, P).
I. Rouzankina et al. / Developmental Biology 265 (2004) 219–233 227formation of the placodes and dermal condensations. This
may be related to its normal expression in the epithelium
lateral to the forming buds. Widespread misexpression of
Dlx2 may maintain elevated proliferation levels throughout
the skin and not allow for local changes in proliferation
necessary for the formation of placodes and dermal con-
densations. These results suggest that DLX factors regulate
cell proliferation during feather bud development.
We also analyzed the levels of cell death in the infected
and uninfected control chicken skin up to the stage of bud
elongation using TUNEL assay. In normal uninfected skin,
cell death was insignificant during feather tract formation.
No change in cell death was observed in the infected skin in
areas of either bud loss or fusion (data not shown).
Dlx2 misexpression induces molecules involved in cell
migration and adhesion, tenascin, and NCAM
To analyze how ectopic Dlx2 influences feather forma-
tion and to begin to determine what are the downstream
factors, we tested if other molecules involved in bud
development were affected. We subjected RCAS/Dlx-2-
infected embryos to RNA in situ hybridizations with probes
to genes normally expressed in the forming feathers, Fgf8,
Bmp2, Bmp4, Bmp7, Shh, Fgf R1, Lef, Msx1, Msx2. Dlx2did not affect any of these molecules except their expres-
sion was induced in areas of bud fusions, and inhibited in
areas of bud loss (data not shown). Therefore, these
molecules did not appear to be directly affected by mis-
expression of Dlx2 and instead appear to reflect alterations
in feather pattern. We also examined the expression of c-
myc, L-myc, and N-myc, which are expressed in the bud
and may be involved in bud proliferation and differentiation
(Desbiens et al., 1991). We did not see any specific changes
except again in areas of bud fusion or loss (data not
shown). Dlx2 did not induce ectopic Dlx5 or Dlx3 expres-
sion, nor did Dlx2 induce itself (data not shown).
The phenotype produced by Dlx2 misexpression re-
sembled the phenotype caused by specific inhibition of
molecules involved in cell adhesion and migration in the
chicken skin explants (Jiang and Chuong, 1992). Inhibi-
tion of tenascin prevents the feather buds from elongating;
they remain round with normal orientation and the hex-
agonal pattern is relatively unaltered. Inhibition of NCAM
with anti-NCAM antibodies leads to uneven distribution
of dermal condensations, resulting in changes of the bud
size and distortion of the hexagonal array. Bud size in
such explants varies: some buds are fused, some are
small, and some are missing. However, these buds can
elongate and retain the correct orientation. In our experi-
Fig. 5. Misexpression of Dlx alters proliferation and induces NCAM and tenascin in the chick skin. Cross sections of the areas of bud fusion and bud loss were
processed with antibodies against myc (to detect exogenous Dlx2), BrDU, NCAM, and tenascin. In the areas of bud fusion (A, C, E, G), myc-Dlx2 is expressed
in the skin epidermis and dermis (A, arrows), cell proliferation is increased (C, arrow), and NCAM (E, arrow) and tenascin (G, arrows) are induced in the skin
epidermis and dermis. In the areas of bud loss (B, D, F, H), myc-Dlx2 is uniformly expressed at high levels throughout the skin epidermis and dermis (B,
arrow). Proliferation is maintained at high levels in the epidermis and dermis (D, arrow). NCAM (F, arrow) and tenascin (H, arrow) are strongly induced in the
epidermis and dermis with tenascin being expressed at higher levels at the border of the two layers.
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of hexagonal array as well as in bud initiation and
morphology: some buds were missing, some buds were
fused and/or were of abnormal shape, some buds were
small. These observations suggested that the expression of
molecules such as NCAM and tenascin could be affected
by ectopic Dlx2.
The expression patterns of NCAM and tenascin have
been published (Chuong and Edelman, 1985; Jiang and
Chuong, 1992) and are briefly described here. Before
placode initiation and during densification of the dermis,
tenascin and NCAM proteins are expressed throughout the
dense dermis at low levels (data not shown). Tenascin and
NCAM then become expressed in the epithelial placode and
in the dermis with tenascin displaying a sharp, strong signal
at the border between the epidermis and the dermis (Figs.
4C, D, G, H). At the asymmetric bud stage, tenascin and
NCAM proteins are detected in the bud anterior dermis and
epithelium with tenascin most strongly expressed at the
border of the two layers (Figs. 4K and L). Later in
development, both molecules are also expressed in a
posterior domain of the bud dermis (Figs. 4O and P).
NCAM and tenascin were strongly up-regulated in
RCAS/Dlx2-infected skin (Fig. 5; n = 5 for each protein)
compared to control (Fig. 4). In the areas of bud loss,
NCAM and tenascin proteins were uniformly induced
throughout the infected dermis and epithelium, with a
stronger signal in the dermis, especially at the border with
the epidermis (Figs. 5F and H). In regions of buds fusion,the asymmetrical pattern of expression of these molecules
was disrupted and their levels were elevated (Figs. 5E and
G). In areas where NCAM and tenascin were not strongly
induced, the buds were not fused, but had an irregular
shape (data not shown). In all the cases of feather pattern
alteration, we observed a concomitant expression of Myc-
DLX2 in the areas of ectopic induction of NCAM and
tenascin. Thus misexpression of DLX2 induces the expres-
sion of adhesion molecules in the chicken skin. This may
lead to changes in cell behavior such as altered cell
aggregation, migration, proliferation, and differentiation
during feather development.
We examined if caBMPR-IB can also induce the expres-
sion of these adhesion molecules. We found that tenascin
and NCAM were strongly induced by ectopic BMP signal-
ing and uniformly expressed in areas of bud inhibition (Fig.
6; n = 3 for each protein). This result may in part explain the
phenomena of bud inhibition by BMPs, as well as suggest
that this effect may be mediated by DLX.Discussion
Early events during feather morphogenesis include the
establishment of a competent field of skin and the induction
of feather primordia in a periodically arranged pattern that
depends on the balance between activators and inhibitors of
feather development. Epithelial–mesenchymal interactions
are essential during establishment of the competent field and
Fig. 6. Activated BMP receptor I induces NCAM and tenascin in the chicken skin. Misexpression of caBMPR-IB in the chick skin causes feather bud loss (A,
C, E). In the areas of caBMPR-IB/RCAS expression (E), strong induction of NCAM (A) and tenascin (C) is observed. Uninjected chick skin sections at the
same stage (st35), in regions where buds are not yet initiated, are shown as a control (B, D).
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although how these interactions are translated into molecu-
lar signals and lead to sequential changes in the epidermis
and dermis is not well understood.
Dlx genes are known to be involved in epithelial–
mesenchymal signaling in several systems such as orofacial
and limb development (Acampora et al., 1999; Bei and
Maas, 1998; Robledo et al., 2002; Thomas et al., 1997,
2000). In this study, we demonstrate that Dlx genes are
expressed in the developing feather buds and their pattern of
expression suggests a role in epidermal–dermal interac-
tions. Dlx2 and Dlx3 are expressed in the presumptive
feather bud field epithelium, then in the epidermal placode,
and later in the bud epidermis. Dlx5 is expressed in the
dermal condensations in the early bud and later its expres-
sion switches to the bud epidermis. These patterns of
expression support the idea that Dlx genes play a role in
the interactions between the epidermis and dermis, espe-
cially at early stages of bud development.
Dlx expression is regulated by feather promoting and
feather inhibiting signals
We have explored the regulation of Dlx expression in
chick skin. It has been shown in several organ systems
that BMPs as well as FGFs can induce Dlx expression
(Bei and Maas, 1998; Thomas et al., 2000). In the
developing feather bud, Bmp expression resembles that
of Dlx genes and caBMP-RIB misexpression induces
ectopic expression of Dlx2, Dlx3, and Dlx5 in the embry-
onic chick skin. This is consistent with the suggested role
of BMPs as upstream regulators of Dlx. The regions of
strong induction of Dlx expression and the regions offeather bud inhibition in most cases are colocalized,
suggesting that DLX proteins could mediate feather bud
inhibition by BMP. Dlx2, Dlx3, and Dlx5 genes were also
induced in the ectopic buds formed around an ectopic
localized source of FGF-4. This suggests that Dlx proteins
could also be involved in mediating a positive role of FGF
in feather bud formation. Thus, Dlx gene expression is
regulated by upstream feather promoting and inhibitory
signals.
Dlx misexpression leads to feather loss and fusion
To understand the function of Dlx genes in feather bud
development, we misexpressed Dlx2 and Dlx5 in the
embryonic chick skin. Misexpression of either Dlx2 or
Dlx5 causes bud loss and bud fusion, as well as abnor-
malities in feather outgrowth and shape, indicating that Dlx
genes play multiple roles in feather development. In
developmentally younger lateral regions with widespread
and strong ectopic expression of Dlx, bud formation is not
initiated and feathers do not form. These regions become
infected at earlier developmental stages either before bud
initiation or during reversible stages of bud initiation. In
developmentally older medial regions, Dlx misexpression
leads to fusion of the feather buds and their outgrowth is
partially or completely disrupted. In medial areas with
limited Dlx misexpression, the feathers develop, but they
have an abnormal shape, similar to the disturbed morphol-
ogy produced by misexpression of BMPs (Noramly and
Morgan, 1998). Thus, during early stages, Dlx genes seem
to promote feather fate and at the same time may repress
bud initiation and outgrowth. These different functions
appear to relate to the levels and distribution of DLX
Fig. 7. Proposed model of the role of Dlx genes in feather development. Before feather initiation, Dlx genes are induced by BMP and FGF signaling and are
expressed uniformly throughout the epidermis. DLX factors induce NCAM and tenascin in the chick skin at low levels. Uniform and low expression of NCAM
and tenascin does not allow dermal condensations to form. When Dlx gene expression becomes restricted to the epidermal placodes and dermal condensations,
DLX factors induce NCAM and tenascin at higher levels in the regions of the placodes and dermal condensations; in other areas of the skin, the expression of
these molecules becomes down-regulated. These events promote local induction of feather buds. In the case of broad Dlx gene misexpression, NCAM and
tenascin are ectopically induced at high levels uniformly throughout the skin. In those areas, feather initiation is inhibited. Dlx misexpression in more limited
regions can lead to feather bud fusions.
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DLX factors act downstream of both positive and negative
signals during feather development. The ability of DLX to
promote or inhibit feather formation is likely to be influ-
enced by other molecules acting in conjunction with DLX
proteins.
DLX may mediate a shift of the competent field into a
feather or interbud fate dependent on the level of expression,
molecular context, and cell environment. This is consistent
with the observation that misexpression of Dlx never in-
duced ectopic buds in the apteric (featherless) regions, but
rather shifted the feather or interbud fate at early develop-
mental stages, when cells are not fully committed to a
particular fate. This also supports the idea that DLX factors
may mediate both feather promoting and inhibitory signal-
ing to help establish a periodicity of the primordia.
DLX affects feather development by altering cell
proliferation and the expression of cell adhesion
and ECM proteins
In many systems, DLX factors are known to promote
cell differentiation at the expense of cell proliferation (a
subset of neurons in basal ganglia, chick chondrocytes and
osteoblasts, basal cells in the mouse skin) (Anderson et al.,
1997a,b; Ferrari and Kosher, 2002; Morasso et al., 1996;
Tadic et al., 2002), although in other cases they are essential
for proliferation and survival of certain cell populations
(central AER cells in Dlx5 / Dlx6 / mouse embry-
onic limbs) (Robledo et al., 2002). In our experiments, cell
proliferation is deregulated by Dlx misexpression. In both
cases of feather bud fusion and loss, it appears that
proliferation in the affected areas is at levels that are lower
than those in the bud yet higher than those in the interbud
with the greatest proliferation in the epidermis and thedermal layers closest to the epidermis. This alteration of
the normal distribution of proliferating cells in Dlx-infected
skin likely changes bud morphology and/or inhibits bud
initiation and outgrowth.
When cells are competent to form feather primordia and
a dense dermis is established, the competition between
positive and negative signals eventually results in the
formation of localized dermal condensations. Formation
of the dermal condensations requires migration of the
dermal cells to the region underlying the epithelial placode.
Changes in cell adhesion are also essential for formation of
dermal condensations (Chuong, 1993; Gallin et al., 1986;
Jiang and Chuong, 1992). Our data indicate that DLX
regulates molecules involved in cell adhesion and migration
(Fig. 7). We show that misexpression of Dlx induces
ectopic NCAM and NCAM is required for proper dermal
condensation formation (Jiang and Chuong, 1992). DLX
also induces tenascin, which plays a role in cell migration,
as well as cell proliferation and differentiation (Chiquet-
Ehrismann et al., 1989; Jones and Jones, 2000; Schmi-
dinger et al., 2003; Tucker, 2001; Vrucinic-Filipi and
Chiquet-Ehrismann, 1993; Zagzag et al., 2002). Through
these molecular interactions, DLX may normally serve to
regulate the formation of localized dermal condensations,
proliferation, and feather outgrowth.
Fig. 7 outlines a model that incorporates a role for Dlx
in the regulation of NCAM and tenascin expression and in
the control of both the promotion and the inhibition of
feather formation. For dermal condensations to form and
feather outgrowth to be initiated, molecules regulating
adhesion and migration should be induced at a particular
time in specific locations. Before the formation of dermal
condensations, Dlx genes are expressed in the skin epi-
dermis in a diffuse pattern. At this stage, NCAM and
tenascin are expressed in the epidermis and dermis at low
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the epidermal placodes and Dlx5 is expressed in the
dermal condensations, tenascin is induced at the epider-
mal/dermal border in the areas of condensation. Tenascin
is generally known to be expressed at sites of epithelial–
mesenchymal interactions during morphological transfor-
mations, such as branching (Ekblom and Aufderheide,
1989; Thesleff et al., 1987). NCAM becomes strongly
expressed in dermal condensations where it is required for
feather formation.
Misexpression of Dlx causes ectopic expression of
NCAM and tenascin, which can lead to an alteration in cell
behavior and disruption of the formation of localized cell
condensations. If NCAM and tenascin are induced relatively
uniformly throughout the skin, dermal condensations or
placodes are unable to form. The inhibition of feather
formation may be related to a potential role for DLX as a
mediator of an inhibitory signal by BMPs, in agreement
with our data that caBMPR-IB activates DLX, NCAM, and
tenascin expression. Misexpression of DLX in more restrict-
ed and developmentally older regions results in induction of
NCAM and tenascin at lower levels and the promotion of
bud fusions in those areas. This indicates a role for DLX in
feather promotion, downstream of FGF and perhaps other
factors. The observation that DLX does not induce the
formation of ectopic buds may be explained by the require-
ment for other signals to promote bud initiation and out-
growth in addition to molecules regulating cell adhesion and
migration.
During the short feather bud stage and later during bud
elongation, DLX factors may be involved in feather
morphogenesis and outgrowth. Limited Dlx misexpression
in developmentally older buds leads to an abnormal shape,
reminiscent of Bmp misexpression. Thus, it is possible that
BMP acts through DLX to control feather morphogenesis.
The downstream targets of this potential pathway are not
yet known but may again be related to the control of cell
proliferation and expression of adhesion and extracellular
matrix molecules. Identification of other molecules that
regulate expression and function of DLX factors as well as
downstream targets of DLX involved in feather develop-
ment will further uncover complex mechanisms of pattern-
ing of the feather primordia.Acknowledgments
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